Literature DB >> 8696944

Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B.

W H Capell1, A Zambon, M A Austin, J D Brunzell, J E Hokanson.   

Abstract

A predominance of small LDL particles (subclass phenotype B), as determined by gradient-gel electrophoresis is found among patients with myocardial infarction. Despite physical differences in phenotype A and B particles, differences in lipid composition of particles in these phenotypes have yet to be reported in an unselected population of males and females. The present study used lipid/apoB ratios to analyze the amount of lipid per LDL particle, isolated by density-gradient ultracentrifugation, in 70 healthy subjects. Relative to apoB, the LDL particles from phenotype B subjects were found to contain less free cholesterol (0.391 +/- 0.05 versus 0.465 +/- 0.05; mean +/- SD; P < .001), phospholipid (1.26 +/- 0.2 versus 1.43 +/- 0.2; P < .001), and cholesteryl ester (1.97 +/- 0.1 versus 2.11 +/- 0.2; P < .001) than particles from phenotype A subjects. The amount of triglyceride per LDL particle did not differ between the two phenotypes (0.410 +/- 0.1 versus 0.406 +/- 0.1; P = NS) despite higher plasma triglyceride levels in the phenotype B subjects. LDL size and buoyancy were positively correlated with particle free cholesterol, phospholipid, and cholesteryl ester but not with particle triglyceride. These data suggest that the physical properties of LDL from subjects with phenotype A and B reflect their lipid composition. The compositional differences between LDL particles of the two phenotypes may provide new insight into the increased risk of myocardial infarction in subjects with small, dense LDL.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8696944     DOI: 10.1161/01.atv.16.8.1040

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  14 in total

1.  Serum lipid profiles, the prevalence of dyslipidemia and the risk factors in two isolated Chinese minorities.

Authors:  Pei-Juan Liao; Rui-Bin Xie; Rui-Xing Yin; Dai-Xun Wei; Jian Huang; Feng Huang; Hui Li; Wei-Xiong Lin; Jin-Zhen Wu; Shang-Ling Pan
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.

Authors:  S D Sibley; J E Hokanson; M W Steffes; J Q Purnell; S M Marcovina; P A Cleary; J D Brunzell
Journal:  Diabetes Care       Date:  1999-07       Impact factor: 19.112

3.  Exchanging carbohydrate or protein for fat improves lipid-related cardiovascular risk profile in overweight men and women when consumed ad libitum.

Authors:  Mario Kratz; David S Weigle; Patricia A Breen; Kaatje E Meeuws; Verna R Burden; Holly S Callahan; Colleen C Matthys; Jonathan Q Purnell
Journal:  J Investig Med       Date:  2010-06       Impact factor: 2.895

4.  Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.

Authors:  Jonathan Q Purnell; Raj K Dev; Michael W Steffes; Patricia A Cleary; Jerry P Palmer; Irl B Hirsch; John E Hokanson; John D Brunzell
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

5.  Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency.

Authors:  J E Hokanson; J D Brunzell; G P Jarvik; E M Wijsman; M A Austin
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

6.  Effects of niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular disease.

Authors:  Alberto Zambon; Xue-Qiao Zhao; B Greg Brown; John D Brunzell
Journal:  Am J Cardiol       Date:  2014-02-11       Impact factor: 2.778

7.  Hypertriglyceridemia is a major factor associated with elevated levels of small dense LDL cholesterol in patients with metabolic syndrome.

Authors:  Yonggeun Cho; Sang Guk Lee; Sun Ha Jee; Jeong Ho Kim
Journal:  Ann Lab Med       Date:  2015-11       Impact factor: 3.464

8.  Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease.

Authors:  James Ronald; Ramakrishnan Rajagopalan; Jane E Ranchalis; Julieann K Marshall; Thomas S Hatsukami; Patrick J Heagerty; Gail P Jarvik
Journal:  Lipids Health Dis       Date:  2009-12-01       Impact factor: 3.876

9.  A rapid 3% polyacrylamide slab gel electrophoresis method for high through put screening of LDL phenotype.

Authors:  Yogendra Singh; Ramakrishnan Lakshmy; Ruby Gupta; Vemparala Kranthi
Journal:  Lipids Health Dis       Date:  2008-11-26       Impact factor: 3.876

Review 10.  Dyslipidemia in obesity: mechanisms and potential targets.

Authors:  Boudewijn Klop; Jan Willem F Elte; Manuel Castro Cabezas
Journal:  Nutrients       Date:  2013-04-12       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.